BlastomaBrain: New in vitro platform for oncology drug development

BlastomaBrain: New in vitro platform for oncology drug development

One of the greatest challenges in drug development is ensuring that the safety and efficacy results from early stages (i.e. from tests on cultured cells or animal models) translate well to administrating the drugs to humans. The gap between the results from these...
InnoSer offers in vivo and in vitro imaging capabilities

InnoSer offers in vivo and in vitro imaging capabilities

InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offer its customers a comprehensive assessment of their models and compounds. Non-invasive and high-throughput kinetic assays with real-time readouts will improve screening...
InnoSer welcomes Edith Simar as its new Business Development Manager

InnoSer welcomes Edith Simar as its new Business Development Manager

Starting from September 2020, Edith Simar joined the InnoSer team as a business development manager. Thanks to her earlier work and connections in Belgium, France, and Luxembourg Edith will especially strengthen InnoSer’s relationships with (prospective) French...
Let’s reconsider your research – InnoSer contract breeding services

Let’s reconsider your research – InnoSer contract breeding services

COVID-19 restrictions brought extra challenges to breeding and maintaining colonies within academic facilities. If you are looking for a service provider resilient to today’s vulnerable environment, InnoSer is here to support you. Let’s put your research back on track...
InnoSer participates in the AACR annual meeting 2020

InnoSer participates in the AACR annual meeting 2020

InnoSer is proud to announce its participation in the annual meeting of the American Association for Cancer Research. As committed contributors to the preclinical oncology field, we look forward to interacting with the community throughout the event. We make this...